By correlating these metabolic variations with Ki-67 levels, our findings complement Yao et al.'s biochemical insights, underscoring the importance of integrating metabolic, genetic, and molecular markers to improve glioma diagnosis and therapeutic planning. Here, MKI67 is linked to glioma.